Yüklüyor......
Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
OBJECTIVE: Episodes of major depressive disorder (MDD) characterized by high levels of anxiety symptoms are less likely to respond to some forms of antidepressant treatment (ADT). This report examines the effects of adjunctive brexpiprazole on depressive symptoms among patients with MDD and anxiety...
Kaydedildi:
| Yayımlandı: | Neuropsychiatr Dis Treat |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6305164/ https://ncbi.nlm.nih.gov/pubmed/30587996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S185815 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|